The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.

The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.

Item
http://www.wikidata.org/entity/Q34064331
CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous tolerance.Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c miceThe proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophagesEffective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifsEnhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapyIn vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences.Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironmentIFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine modelHSP70/CD80 DNA vaccine inhibits airway remodeling by regulating the transcription factors T-bet and GATA-3 in a murine model of chronic asthma.Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids.DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.Nucleofection of expression vectors induces a robust interferon response and inhibition of cell proliferation.Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection.Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences
P2860

The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.

Item
http://www.wikidata.org/entity/Q34064331
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@ast
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@en
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@nl
type
label
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@ast
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@en
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@nl
prefLabel
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@ast
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@en
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
@en
P2093
P304
P31
P433
P478
P577
P698